Search - tctmd.com

Displaying 201 - 220 of 273

Presentation TCT 2013

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone

January 31, 2013

News Daily News

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Caitlin E. Cox

December 19, 2012

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Los Datos de un Registro Norteamericano Avalan Someter a los Pacientes STEMI a PCI Transradiales

Caitlin E. Cox

December 19, 2012

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

L.A. McKeown

December 05, 2012

News Daily News

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

L.A. McKeown

November 28, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

Presentation

Bivalirudin for Primary PCI

Presenter: B. Hibbert

November 26, 2012

Presentation TCT 2012

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Presenter: Rajesh Dave

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

Bivalirudin: New Analyses, New Studies

Presenter: Gregg Stone

October 24, 2012

Presentation TCT 2012

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

Presenter: James Hermiller Jr

October 23, 2012

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Jason Kahn

October 19, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

Presentation

Bivalirudin vs. Heparin Plus a GPI in Pts with NSTEMI Undergoing PCI After Clopidogrel Pretreatment

Presenter: G. Ndrepepa

October 18, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

October 12, 2012

Advertisement

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Los Datos de un Registro Norteamericano Avalan Someter a los Pacientes STEMI a PCI Transradiales

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Bivalirudin for Primary PCI

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Bivalirudin: New Analyses, New Studies

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Bivalirudin vs. Heparin Plus a GPI in Pts with NSTEMI Undergoing PCI After Clopidogrel Pretreatment

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content